Introduction
============

Hepatocellular carcinoma (HCC) is one of the most devastating malignancies worldwide [@B1]. During the past 20 years, the detection of patients with early-stage hepatocellular carcinoma (E-HCC) has increased, and surgery has greatly improved patients\' survival, with a 5-year survival of 70% [@B2]. However, about half of E-HCC patients relapse after surgery [@B3] and metastatic spread is responsible for most E-HCC- associated morbidity and mortality [@B4]. Investigation of molecular mechanisms of E-HCC metastasis could identify prognostic biomarkers and/or useful therapeutic targets. E-HCC metastasis is a multistep process and is known to be regulated by the tumor microenvironment [@B5]. Although hypoxia in E-HCC has been studied extensively, dysregulated pH is less recognized in E-HCC, especially in oxygenated conditions. It is believed that dysregulation of the pH gradient in and around cancer cells, with intracellular pH (pHi) higher than 7.4 and extracellular pH (pHe) between 6.6 -7.2, creates a favorable environment for metastatic progression [@B6].

Extracellular acidification around E-HCC can be attributed to increased glycolysis in cancer cells. HCC cells in both primary and early malignant lesions consume glucose at a high rate even in oxygenated environments, a phenomenon known as Warburg effect [@B7]. Abnormal blood perfusion and hypoxia, coupled with a glycolytic phenotype, generate a pH gradient from the inner tumor region to adjacent normal tissues. This dysregulated pH gradient promotes cancer cell proliferation, metabolic adaptation, and migration and/or invasion both *in vitro* and *in vivo* [@B8], [@B9]. Treatments with pH-balancing reagents, such as bicarbonate, imidazole, and lysine, to neutralize tumor-derived acid can inhibit spontaneous and experimental metastasis [@B10], [@B11]. Extracellular acidification not only alters expression of metabolism-related genes, such as glucose transporter 1 (*GLUT-1*), carbonic anhydrase (*CA-IX*), or sodium-hydrogen exchanger 1 (*NHE-1*), it also activates some pH-dependent proteins that are involved in pro-metastatic transformation [@B12]. Recent studies revealed that normoxic acidosis triggers pH-dependent nucleolar sequestration of von Hippel-Lindau (VHL) protein, leading to activation of hypoxia-inducible factors (HIFs) [@B13], both of which regulate the transcription of numerous genes that are involved in metabolism, angiogenesis, cell proliferation, and metastasis. [@B14], [@B15].

Exosomes are membrane vesicles that are 30-100 nm in size and are released into the extracellular environment by various cell types. Although initially considered as "garbage transporters" from parental cells, exosomes are now recognized as a new category of intercellular communicators. Cells constitutively sort envelope proteins and RNAs into exosomes, a process that can be stimulated by a variety of pathophysiologic stimuli [@B16]. Exosomes bear surface molecules that render their attachment to target cells and activate signaling systems via ligand-receptor interactions or endocytosis. Through receiving a specific set of exosomes into the cytosol, a recipient cell modulates its physiological state [@B17]. Many studies have demonstrated that tumor-secreted exosomes can promote angiogenesis, modulate the immune system, support tumor progression, and remodel surrounding parenchymal tissues to promote pro-metastatic adaptation [@B18]. Exosomes isolated from the serum of cancer patients have been associated with tumor metastasis and/or relapse [@B19]. Taken together, tumor-derived exosomes are critical mediators of cancer progression. A recent report indicated that the acidic microenvironment promotes the release of exosomes [@B20]. In the present study, we investigated the relationship between the acidic microenvironment and exosomes with the aim to identify recurrence and/or metastasis-related biomarkers for designing new strategies to treat E-HCC.

Materials and Methods
=====================

Cell culture and development of acidic microenvironment culture
---------------------------------------------------------------

The human HCC cell lines SMMC-7721 and Hep3B were purchased from the China Center for Type Culture Collection (Wuhan, China) and the American Type Culture Collection (Manassas, VA, USA), respectively. Cells were cultured in Dulbecco\'s modified Eagle\'s medium (Invitrogen, Carlsbad, CA, USA) with 10% newborn calf serum at 37℃ with 5% CO~2~. Vesicle-depletion was performed by centrifuging cell culture medium at 100,000 g overnight. To simulate the tumor pH microenvironment, the cell culture medium was supplemented with 25 mmol/L PIPES (pH adjusted to 7.4) and 25 mmol/L of HEPES (pH adjusted to 6.6) as described previously [@B21]. Low pH-adapted cells were cultured and passaged directly in pH 6.6 medium for at least 4 weeks.

Exosome isolation and labeling
------------------------------

HCC cells (1×10^6^) were cultured in vesicle- depleted medium for 48-72 hours. The medium was gathered and subjected to gradient centrifugation. Briefly, the medium was first centrifuged at 1000g for 10 min, at 3000g for 30 min, at 10,000g for 60 min, at 100,000g for 4 hours. All centrifugal steps were performed at 4 ℃. Exosomes from sera of HCC patients were isolated using ExoQuick exosome precipitation solution (SBI System Biosciences) according to the manufacturer\'s instructions [@B22]. The extracted exosomes were suspended in 300 μL PBS. The exosomes were quantified by BCA protein assay. A total of 10 µg exosomes were used for each*in vitro* experiment. For *in vivo* growth and metastasis assays, 1 µg/g exosomes were applied three times a week. We also used fluorescent dye Dil (Sigma) to label exosomes. Briefly, exosomes were incubated with Dil (1:2000) for 2 hours and then washed with PBS. The endocytosis of recipient cells was visualized using a confocal fluorescence microscope (Zeiss).

Patients
--------

One hundred twenty-four surgery patients diagnosed with E-HCC at Sun Yat-sen University Cancer Center from January 1, 2009 to December 30, 2012 were screened in this study. E-HCC was defined as solitary tumors with diameters of \< 5 cm and without vascular invasion [@B23]. A patient was excluded from the study if he or she had transarterial chemoembolization (TACE), radiotherapy, ablation, or liver transplant before resection. Patients were also excluded if they had no definitive diagnosis or follow-up data. The tumor stage and clinical stage were established using the 2003 Union for International Cancer Control/American Joint Committee on Cancer criterion. Healthy volunteers\' blood samples were used as a control. All samples were obtained with informed consent. The study protocol was approved by the Institutional Review Board. The clinical-pathologic characteristic of the E-HCC patients are summarized in Table [1](#T1){ref-type="table"}.

Tissue pH measurement
---------------------

The tissue pH was measured by microelectrode. Briefly, tissues were obtained from HCC patients or xenografted nude mice after surgery. The tissue pH was measured by inserting the glass electrode (LabSen 252, Sanxin, Shanghai, China) into the center of tumor tissues, as directed by the manufacturer\'s instruction. The center part from each tumor was selected and extracted for analyzing the mRNA expression of*GLUT-1*, *CA9, MMP3,* and*MMP9* by Q-PCR and their correlation with the pH value in the same region of HCC tissues. The value of tissue pH was measured in triplicate for each sample.

Electron microscopy
-------------------

The exosomes were examined by transmission electron microscopy as previously described [@B24]. Briefly, the samples were fixed with 2% glutaraldehyde and loaded on to Formvar carbon at room temperature. Subsequently, the samples were negatevely stained with 1% uranyl acetate for 3 minutes at 4 ℃, and dried under an electric incandescent lamp for 10 minutes. Photographs were taken using the JEM-1400 transmission electron microscope (JEOL, Tokyo, Japan) at 120 kV.

RNA isolation and quantitative real-time PCR
--------------------------------------------

Total RNA was extracted by using TRIzol reagent (Invitrogen). cDNA was synthesized using the PrimeScript RT reagent Kit (Promega, Madison, WI, USA) as previously described [@B25]. Real-time PCR was performed using an ABI 7900HT Fast Real-time PCR system (Applied Biosystems, Foster City, California, USA) as previously described [@B25].

Oligonucleotide transfection, lentiviral packaging
--------------------------------------------------

GLUT-1 siRNA, CA9 siRNA, miR-21-5p siRNA, miR-10b-5p siRNA, miR-21 mimics, miR-10b mimics, HIF-1α shRNA and HIF-2α shRNA were synthesized by Kangcheng biotechnology company (Guangzhou, China). The pCDH-CMV-MCS-EF1-coGFP plasmid was used to construct virus particles. This plasmid, together with packaging plasmids pCMV/pVSVG, pRSV/pREV, and pMDLG/pRRE, were transfected into 293FTcells using Lipofectamine 2000 reagent (Invitrogen). After 48 hours, virus particles were harvested from the cell supernatant. SMMC-7721 and Hep3B cells were transfected with centrifuged lentivirus plus 8 mg/ml polybrene (Sigma, St Louis, MO, USA). Oligonucleotide transfection was performed with Lipofectamine 2000 reagent (Invitrogen). U6 snRNA was used as a positive control, and reactions without reverse transcriptase or RNA template were included as negative controls.

PDCM system
-----------

The nanoparticles (PDCM) are composed of 1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine (POPC), 1,2-dioleoyl-snglycero-3-phosphoethanolamine (DOPE), cholesteryl hemisuccinate (CHEMS), and cholesteryl-4-((2-(4-morpholinyl) ethyl) amino)-4-oxoburanoate (MOCHOL). The designed nanoparticles have "pH-tunable" characteristic, which facilitates efficient delivery relying on the surrounding pH [@B26]. Preliminary experiments and clinical trials showed good systemic biodistribution of the PDCM system [@B26]-[@B28]. PCDM-GLUT-1, PDCM-CA9, PDCM-miRNA- 21, and PDCM-miRNA-10b were synthesized and assembled by Kangcheng biotechnology company (Guangzhou, China).

miRNA microarray
----------------

Sample preparation and miRNA microarrays (Human miRNA Microarray, Release 21.0, Agilent) were performed at Biomedlab Company (Shanghai, China). Briefly, total RNA (2.5 μg) extracted from exosomes was labelled with pCp-DY647 (Dharmacon, Lafayette, CO, USA), hybridized onto microarray, scanned using a LuxScan 10K Microarray Scanner (CapitalBio, Beijing, China) and analyzed using GenePix Pro 6.0 software (Axon Instruments, Foster City, CA, USA). The microarray data have been deposited online under accession number GSE118647.

MTT assay
---------

MTT proliferation assay (Sigma) was performed according to the manufacturer\'s protocol. A total of 10 µg exosomes was used for each group according to the experimental design. Viability was measured at different time points from 12 h to 72 h after treatment.

Scratch assay
-------------

The scratch assay was used to measure cell migration *in vitro*. In brief, cells were seeded in 60mm dishes and cultured until they formed a fused monolayer. A P200 pipette tip was used to create a scratch following which cells were incubated with different exosomes (10 µg). After 48 h, wound closure was photographed by a microscope. The migration rate was measured by the fraction of cell coverage across the scratch. The migration rate (%) = migration area/total area ×100%.

Invasion assay
--------------

Matrigel invasion chambers (BD Biosciences, NJ, USA) were used to measure cell invasion. A total of 10 µg exosomes was used for each group according to the experimental design. Briefly, 1×10^4^ cells were added to the upper chamber, and FBS was added to the lower chamber. After 48 h, the chambers were fixed and stained with 0.05% crystal violet for 2h. The cells on the upper surface were gently scraped. The stained cells were counted and photographed under a microscope (×200).

Immunohistochemistry and immunofluorescence
-------------------------------------------

The slides were dried, dewaxed, rehydrated, and blocked. Next, the sliders were boiled and then incubated with the anti-HIF-1α antibody (1:500, ProteinTech Group, Inc.) and anti-HIF-2α antibody (1:500, ProteinTech Group, Inc.) in a moist chamber. After 3 washes, the slides were incubated with a secondary antibody (Envision, Dako, Glostrup, Denmark) and then stained with DAB (3,3-diaminobenzidine). Nuclei were stained with hematoxylin. The cutoff value (45% positive cells) of HIF-1α/ HIF-2α immunoreactivity was determined by receiver operator curve (ROC) analysis. For immunofluorescence, slides were incubated with rabbit anti-E- cadherin (1:200, Abcam) and mouse anti-vimentin (1:200, Abcam) for 2 hours. Slides were incubated for 1 hour with Alexa Fluor 488 goat anti-mouse IgG (1:800, Cell Signaling Technology) and Alexa Fluor 594 goat anti-rabbit IgG (1:800, Cell Signaling Technology).

Western blot analysis
---------------------

Western blotting was performed using standard procedures. Briefly, protein samples (25mg) were separated on polyacrylamide-SDS gels and electrophoretically transferred to polyvinylidene difluoride membranes (Millipore). Subsequently, membranes were blocked and incubated with mouse anti-CD81 (1:1000, Abcam), mouse anti-CD63 (1:1000, Abcam), mouse anti-HIF-1α (1:1500, ProteinTech Group, Inc.), mouse HIF-2α (1:1500, ProteinTech Group, Inc.), rabbit anti-PTEN (1500, Abcam), rabbit anti-E-cadherin (1:1000, Abcam), mouse anti-vimentin (1:1000, Abcam), rabbit anti-mTOR (1:1000, Abcam), rabbit anti-AKT (1:1000, Abcam), rabbit anti-pAKT (1:1000, Abcam), and rabbit anti-tubulin (1:1000 Abcam) antibodies. Anti-rabbit or anti-mouse IgG was used as the secondary antibody (1:8000). The signal intensity was evaluated using Quantity One 4.4.0 software.

*In vivo* growth and metastasis assay
-------------------------------------

The *In vivo* growth and metastasis assay were performed as previously described [@B29] and are illustrated in Supplementary Figure [S14](#SM0){ref-type="supplementary-material"}. Briefly, for *in vivo* growth assays, 2×10^6^ SMMC-7721 cells were injected subcutaneously into the flanks of BALB/ C-nu/nu athymic nude mice. The tumor size was measured using Vernier calipers every 7 days. For*in vivo* metastasis assay, the subcutaneous tumors were resected from growth assays and formed into 1mm^3^ cubes. These tumor cubes were implanted in the left lobes of the livers of nude mice. Exosomes (three times a week, 1 µg/g for each time) were used for *in vivo* growth and metastasis assay. On day 50, the liver and lung were dissected, fixed by formalin, and stained with haematoxylin & eosin. Consecutive tissue sections were used to examine pulmonary metastatic nodules. All experimental procedures involving animals were performed according to the institutional ethical guidelines.

Chromatin immunoprecipitation (ChIP) assay
------------------------------------------

The ChIP Assay Kit (Abcam) was used according to the manufacturer\'s protocol. Briefly, cells were lysed in cell lysis buffer to generate DNA fragments. Nonspecific IgG (1:200, Sigma), mouse anti-HIF-1α (1:200, Abcam), and rabbit anti-HIF-2α antibodies (1:200, Abcam) were incubated with lysates to precipitate target regions. The promoter fragment (contain HIF response element, HRE) was extracted and visualized by gel. The region of the miR-130b promoter was used as a negative control.

LASSO Logistic regression
-------------------------

The least absolute shrinkage and selection operator (LASSO) is an alternative method for fitting sparse models for regression with high-dimensional predictors. To eliminating variables, the L1 penalty could force coefficient estimates to zero [@B30], [@B31]. The logistic regression model with LASSO penalty was used to achieve variable shrinkage and selection. Optimal values of λ were determined by repeated cross-validations. The optimal λ is the largest value for which the partial likelihood deviance is within 1-s.e. of the smallest value of partial likelihood deviance. R software version 3.0.1 (R Foundation for Statistical Computing) and the \'glmnet\' package were used to perform the LASSO regression analysis.

Statistical analysis
--------------------

SPSS software (SPSS Standard v 17.0) was used to perform statistical analysis. The most functional miRNAs with non-zero coefficients were determined by LASSO logistic regression in TCGA dataset. The correlation between serum exosomal miR-21 and miR-10b levels and clinical-pathologic features was assessed with the Chi-square test. Survival curves were calculated by Kaplan-Meier analysis and compared by the log-rank test. Multiple Cox proportional hazards regression analysis was performed to assess the survival variables. Data are presented as mean ± SE and assessed by the student\'s test. *P* values \< 0.05 were considered significant.

Results
=======

The acidic microenvironment in HCC is correlated with poor survival of patients
-------------------------------------------------------------------------------

We first analyzed the TCGA-HCC database to screen for genes that are related to the acidic microenvironment and correlated with HCC patients\' survival (Supplementary Figure [S1](#SM0){ref-type="supplementary-material"}). We found that *GLUT-1*, *CA9*, *GCK*, *NHE1,* and *CA12* expression was significantly increased in HCC samples compared to adjacent normal tissues (*P* \< 0.05, Figure [1](#F1){ref-type="fig"}A and Supplementary Figure [S2](#SM0){ref-type="supplementary-material"}). Furthermore, Kaplan- Meier and ROC analyses showed that the expression of *GLUT-1* and *CA9* was significantly correlated with poor overall survival of HCC patients (*P* \< 0.001, Figure [1](#F1){ref-type="fig"}B and Supplementary Figure [S3](#SM0){ref-type="supplementary-material"} and S4). We examined *GLUT-1* and *CA9* expression in fresh tissues from 20 E-HCC patients and found that they were negatively correlated with extracellular pH (*P* \< 0.05, Figure [1](#F1){ref-type="fig"}C). The activity of MMP-3 (matrix metalloproteinase-3) and MMP-9 (matrix metalloproteinase- 9) was reported to be high in acidic microenvironment [@B32]-[@B35]. Therefore, we first confirmed significantly increased expression of *MMP-3* and*MMP-9* in the acidic microenvironment in HCC cell lines (*P* \< 0.05, Figure [1](#F1){ref-type="fig"}D). The expression of these two metalloproteases was also negatively correlated with extracellular pH in fresh tissues of 20 E-HCC patients (Figure [1](#F1){ref-type="fig"}E). Also, *MMP-3* and*MMP-9* expression was significantly correlated with poor overall and disease-free survival (DFS) in TCGA-HCC database and SYSUCC E-HCC patients (*P* \< 0.05, Figure [1](#F1){ref-type="fig"}F and [1](#F1){ref-type="fig"}G).

To evaluate the role of extracellular pH on HCC cell proliferation and metastasis *in vivo*, we took advantage of specialized liposomes (PDCM, trade name SMARTICLES), which facilitate transmembrane diffusion in a pH-dependent manner. Based on PDCM molecular properties, PDCM-CA9 and PDCM- GLUT-1 could significantly decrease *CA9* and *GLUT-1* levels in HCC cells (*P* \< 0.05, Supplementary Figure [S5](#SM0){ref-type="supplementary-material"}A and S5B). Knocking-down expression of *CA9* and *GLUT-1*, as well as NaHCO~3~ injection, could elevate the acidic pHe [@B12], [@B36], [@B37]. NaHCO~3~, PDCM-CA9, PDCM-GLUT-1, and PDCM-CA9 + PDCM-GLUT-1 could increase extracellular pH and decrease tumor growth and lung metastases, indicating that low extracellular pH may play a role in tumor proliferation and invasion (*P* \< 0.05, Figure [1](#F1){ref-type="fig"}H, 1I, and 1J).

Exosomes derived from HCC cells cultured under acidic condition promote cell migration and invasion of recipient HCC cells cultured under the normal condition
--------------------------------------------------------------------------------------------------------------------------------------------------------------

We isolated extracellular vesicles from the medium of HCC cells (SMMC-7721 and Hep-3B) cultured under pH 6.6 and pH 7.4 by multistep ultracentrifugation. Western blot analysis showed that the nanovesicles expressed exosome markers CD63 and CD81 (Figure [2](#F2){ref-type="fig"}A). Transmission electron microscopy showed diameters of extracellular vesicles ranging from 50 to 200 nm (Figure [2](#F2){ref-type="fig"}C). These nanovesicles were homogeneous in appearance and showed features of exosomes.

To test whether exosomes derived from HCC cells cultured under acidic condition could influence the biological behavior of recipient cells, we first performed fluorescence microscopy to visualize the endocytosis of exosomes by recipient cells. As shown in Figure. 2D, Dil-labeled exosomes derived from HCC cells cultured under acidic condition were endocytosed by normal HCC cells after incubation for 2 hours. Subsequently, we investigated the effects of acidic condition-derived exosomes on oncogenic properties of non-acidic HCC cells, including cell proliferation, migration, and invasion. MTT, invasion and migration assays showed that acidic HCC- derived exosomes significantly increased cell proliferation, migration, and invasion of recipient cells compared with non-acidic HCC-derived exosomes (Figure [2](#F2){ref-type="fig"}E, 2F, 2G, and Supplementary Figure [S6](#SM0){ref-type="supplementary-material"}). As previously reported, we verified that acidifying the extracellular milieu of HCC cells could trigger the activation of HIF-1α and HIF-2α in normoxia (Figure [2](#F2){ref-type="fig"}B). Intriguingly, exosomes derived from HIF-1α and HIF-2α knockdown (KD) cells cultured under acidic condition could not increase cell proliferation, migration, and invasion (Figure [2](#F2){ref-type="fig"}E, 2F, 2G, and Supplementary Figure [S6](#SM0){ref-type="supplementary-material"}).

Identification of candidate functional miRNAs in acidic HCC cell-derived exosomes
---------------------------------------------------------------------------------

It is well known that exosomes could deliver both mRNAs and miRNAs to recipient cells and affect cellular functions [@B38]. To identify exosomal miRNAs that may play an oncogenic role, we performed comparative microarray profiling of miRNAs derived from exosomes from the supernatant of SMMC-7721 cells cultured under normal (pH 7.4) or acidic conditions (pH 6.6) for at least 4 weeks.

Five hundred forty-five and 802 known miRNAs were identified in acidic and non-acidic exosomes, respectively, of which 535 miRNAs were shared by both (Figure [3](#F3){ref-type="fig"}A). We compared the expression levels of miRNAs between acidic and non-acidic exosomes. Using a threshold cutoff of 3-fold and *P* \< 0.05, we discovered that expression of 81 miRNAs was significantly different between the two kinds of exosomes (Supplementary Table [S1](#SM0){ref-type="supplementary-material"}), of which 70 miRNAs were upregulated in acidic exosomes compared with non-acidic exosomes. Gene ontology (GO) and KEGG analysis showed that genes regulating EMT (epithelial-mesenchymal transition) and PI3K- AKT signaling were among top upregulated clusters. (Figure [3](#F3){ref-type="fig"}B, Supplementary Figure [S7](#SM0){ref-type="supplementary-material"} and S8).

To further identify the functional miRNAs in acidic HCC-derived exosomes, we analyzed 49 paired HCC and adjacent normal tissues in the TCGA data set to identify differentially expressed miRNAs in these samples. The volcano plot showed that the 84 miRNAs showed more than 2-fold change in the 49 pairs of samples (*t*-test, all *P* \< 0.0001, Figure [3](#F3){ref-type="fig"}C). We used a LASSO (the least absolute shrinkage and selection operator) logistic regression model to analyze the 84 miRNAs and found that 18 had non-zero coefficients (Figure [3](#F3){ref-type="fig"}D and Supplementary Figure [S9](#SM0){ref-type="supplementary-material"}). miR-21 and miR-10b were upregulated in both TCGA dataset and exosome microarray analyses and therefore were considered as the most important functional miRNAs in acidic HCC-derived exosomes (Figure [3](#F3){ref-type="fig"}E).

Acidic condition stimulates exosomal miR-21 and miR-10b expression in HIF-1α and/or HIF-2α-dependent manner
-----------------------------------------------------------------------------------------------------------

We further confirmed the miRNA microarray results by real-time PCR. Consistent with the microarray results, exosomes secreted from HCC cells cultured under pH 6.6 had higher levels of miR-10b, miR-21, miR-223, and miR-940 than those derived from cells cultured under pH 7.4 condition (Figure [4](#F4){ref-type="fig"}A). We focused on miR-21 and miR-10b for further study because they were extracted from the LASSO logistic model and were higher in acidic exosomes (Figure [3](#F3){ref-type="fig"}E). Under normal condition, cellular and exosomal levels of miR-21 and miR-10b were not influenced by knocking-down either HIF-1α or HIF-2α (Figure [4](#F4){ref-type="fig"}B and [4](#F4){ref-type="fig"}C). However, under acidic condition, knocking-down HIF-1α or HIF-2α led to decreased levels of both cellular and exosomal miR-21 and miR-10b (Figure [4](#F4){ref-type="fig"}B and [4](#F4){ref-type="fig"}C). We also used an additional HCC cell line Hep3B to confirm these results (Supplementary Figure [S10](#SM0){ref-type="supplementary-material"}).

HIF-1α and HIF-2α bind to the HRE sites in promoters. We next performed ChIP assay to validate the binding of HIF-1α and HIF-2α to the HRE regions of miR-21 and miR-10b promoters. As shown in Fig [4](#F4){ref-type="fig"}D, anti-HIF-1α or HIF-2α antibodies immunoprecipitated genomic DNAs containing miR-21 and miR-10b HRE-containing promoter regions in cells cultured under pH 6.6 conditions. In contrast, the miR-130 promoter region (without HRE region) did not show recruitment of HIF-1α or HIF-2α under acidic condition. The levels of miR-21 and miR-10b were higher in SMMC-7721 and Hep3B cell lines cultured under acidic condition than non-acidic condition (*P* \< 0.05, Figure [4](#F4){ref-type="fig"}E). Also, after transfection of miR-21/10b into both HCC cell lines, we found that the levels of exosomal miR-21 and miR-10b were substantially increased in cells cultured under acidic condition (Figure [4](#F4){ref-type="fig"}F). These data provided evidence that in HCC cells cultured under acidic condition, increased HIF-1α and HIF-2α could directly bind to the HRE-containing promoter regions of miR-21 and miR-10b and up-regulate their cellular expression. The increased cellular expression of miR-21 and miR-10b may result in the elevated levels of these miRNAs in exosomes. However, the precise mechanism for increased loading of these miRNAs in exosomes remains unclear and needs to be investigated. Furthermore, silencing HIF-1α and/or HIF-2α in SMMC-7721 and Hep3B cells under acidic condition resulted in decreased levels of cellular miR-210 (another target of HIF-1α), whereas the levels of exosomal miR-210 were not altered (Supplementary Figure [S11](#SM0){ref-type="supplementary-material"}). These results indicated complex regulation of expression for individual miRNAs and their loading into exosomes.

miR-21 and miR-10b mediate acidic exosome-induced HCC cell proliferation, migration, and invasion
-------------------------------------------------------------------------------------------------

Knockdown of miR-10b and miR-21 in acidic exosomes significantly decreased cell proliferation, migration, and invasion of recipient cells compared with non-acidic-induced exosomes (Figure [5](#F5){ref-type="fig"}A-[5](#F5){ref-type="fig"}E, Supplementary Figure [S12](#SM0){ref-type="supplementary-material"}). To study whether cell migration and invasion induced by miR-21 and miR-10b from acidic exosomes depend on HIF-1α or HIF-2α, we overexpressed miR-21 and miR-10b in HIF-1α- or HIF-2α knocked-down cells. Transfection of miR-21 and miR-10b mimics in HIF-1α- or HIF-2α knocked-down cells restored miR-21 and miR-10b levels in exosomes (Supplementary Figure [S13](#SM0){ref-type="supplementary-material"}). Furthermore, restoration of miR-21 and miR-10b levels in acidic exosomes increased recipient cell proliferation, migration, and invasion (Figure [5](#F5){ref-type="fig"}F-[5](#F5){ref-type="fig"}J). We also examined whether exosomal miR-21 and miR-10b induced EMT-related changes in HCC cells, and found that exosomal miR-21 and miR-10b increased Vimentin and Snail expression while decreased PTEN and E-cadherin levels in treated cells (Figure [6](#F6){ref-type="fig"}A). These results suggested that acidic exosome-induced cell migration and invasion were dependent on miR-21 and miR-10b and these two exosomal miRNAs could also induce EMT in the recipient cells.

Acid-derived exosomal miR-21 and miR-10b promote HCC cell growth and metastasis in a xenograft model
----------------------------------------------------------------------------------------------------

We used a xenograft model and a lung metastasis model to investigate the effects of tumor- derived exosomes on tumor growth and metastasis (Supplementary Figure [S14](#SM0){ref-type="supplementary-material"}). Overexpression of miR-21 and miR-10 in acid-derived exosomes increased tumor growth and tumor volume. The tumor volume and numbers of lung metastases were significantly increased in mice injected with acid-treated or miR- 21/10b-overexpressing exosomes-treated cells (Figure [6](#F6){ref-type="fig"}B and [6](#F6){ref-type="fig"}C). Knock-down of miR-21 and miR-10b expression in acidic exosomes significantly decreased the tumor volume and numbers of lung metastases (Figure [6](#F6){ref-type="fig"}B and [6](#F6){ref-type="fig"}C). We also investigated whether exosomal miR-21 and miR-10b regulated EMT *in vivo.* Consistent with the *in vitro* experiments, the expression of Vimentin was increased, while the expression of E-cadherin was decreased in acid-treated and miR-21/10b-overexpressing exosomes (Figure [6](#F6){ref-type="fig"}D and [6](#F6){ref-type="fig"}E, Supplementary Figure [S15](#SM0){ref-type="supplementary-material"}).

miR-21 and miR-10b derived from exosomes are correlated with disease-free survival in E-HCC patients
----------------------------------------------------------------------------------------------------

We next isolated and examined the exosomes from sera of patients with E-HCC and healthy volunteers. Electron microscopy showed that the precipitated vesicles had the same size distribution consistent with exosomes (50-200 nm) (Figure [7](#F7){ref-type="fig"}A). The expression of miR-21 and miR-10b in E-HCC patient exosomes was significantly increased compared with that in exosomes from healthy volunteers (Figure [7](#F7){ref-type="fig"}B). We also found that the exosomes derived from the sera of E-HCC patients could increase cell proliferation, migration, and invasion compared with exosomes from healthy volunteers (Figure [7](#F7){ref-type="fig"}C and [7](#F7){ref-type="fig"}D). Furthermore, the expression of miR-21 and miR-10b was negatively correlated with extracellular pH in fresh tissues from 20 E-HCC patients (Supplementary Figure [S16](#SM0){ref-type="supplementary-material"}).

In 124 E-HCC patients who underwent surgery, serum exosomal miR-21 and miR-10b levels were closely associated with tumor size, cell differentiation, and recurrence. (Table [1](#T1){ref-type="table"}). HIF-1α and HIF-2α expression were used to determine the correlation between exosomal miR-21 and miR-10b and acidic microenvironment (Supplementary Figure [S17](#SM0){ref-type="supplementary-material"}). As shown in Table [2](#T2){ref-type="table"}, serum exosomal miR-21 and miR- 10b significantly correlated with HIF-1α and HIF-2α staining. Kaplan-Meier analysis revealed that high expression of serum exosomal miR-21 and miR-10b was associated with poor disease-free survival (Figure [7](#F7){ref-type="fig"}E). Multivariate Cox regression analysis also indicated that high levels of serum exosomal miR-21 and miR-10b were independent prognostic factors for the poor survival of E-HCC patients (Table [2](#T2){ref-type="table"}). ROC analysis demonstrated that as prognostic factors, sensitivity and specificity of exosomal miR-21 and miR-10b were significantly higher than tissue miR-21/miR10b and AFP (Figure [7](#F7){ref-type="fig"}F). We further developed a nano-drug targeting exosomal miR-21 and miR-10b based on the PDCM system. In an *in vivo* assay, both PDCM-miR-21 and PDCM-miR-10b could significantly decrease tumor growth and numbers of metastatic lung nodules, indicating that exosomal miR-21 and miR-10b could serve as potential therapeutic targets (Figure [7](#F7){ref-type="fig"}G and [7](#F7){ref-type="fig"}H).

Discussion
==========

In this study, we found that the acidic tumor microenvironment correlated with poor survival of HCC patients. Our results showed that acidic microenvironment increased HCC cell-derived exosomal miR-21 and miR-10b levels, which could promote migration and invasion of recipient HCC cells cultured under normal conditions both*in vivo* and *in vitro*. Also, we found that the levels of miR-21 and miR-10b in exosomes isolated from the sera of patients correlated with advanced tumor stage. Furthermore, exosomal miR-21 and miR-10b were independent prognostic factors for poor disease-free survival of patients with E-HCC and could serve as potential therapeutic targets. To the best of our knowledge, this is the first study illustrating that acidic tumor microenvironment can promote HCC cell proliferation and/or metastasis by delivering exosomal miR-21 and miR-10b.

Exosomes have been shown to participate in tumor progression, but the association between exosomes and acidic microenvironment, especially in E-HCC, had not been described. Here, by using the TCGA dataset, we showed that expression of pH-related genes was associated with HCC patient survival. We further found that low pH culture conditions could dramatically induce the release of exosomes in HCC cell lines. These acidic pH-derived exosomes substantially promoted proliferation, migration, and invasion of recipient tumor cells cultured in the normal non-acidic medium. Our results suggested that HCC cells can easily be induced to a pro-metastatic phenotype by acidic pH-derived exosomes.

It is known that exosomes function as a bridge between cells and the microenvironment by transferring biological molecules, especially mRNAs and miRNAs [@B39]. In the present study, we focused on exosomal miRNAs and their effects on tumor proliferation and metastasis. Using miRNA microarrays and a 3-fold cutoff, we identified 31 upregulated and 50 downregulated miRNAs in exosomes cultured in acidic-condition compared with those cultured in normal condition. The results also indicated that the packaging of exosomal miRNAs may be affected by different culture conditions, especially by acidic pH. We further compared the differential miRNAs in patient\'s tissues by exploring TCGA dataset. LASSO logistic regression analysis was used to shrink miRNA candidates [@B40]. Based upon the results from the LASSO logistic model combined with our microarray analysis, we hypothesized that the acidic exosomal miRNA-21 and miR-10b are remarkably correlated with tumor progression.

miR-21 and miR-10b are associated with cell proliferation, apoptosis, and invasion by targeting tumor suppressor genes in many types of human cancers [@B41], [@B42]. It has been reported that both miR-21 and miR-10b contained an HRE region and could be induced by HIF-1α and HIF-2α and by pH-dependent nucleolar sequestration of von Hippel-Lindau (VHL) protein [@B13], [@B43], [@B44]. We, therefore, further investigated the functions of exosomal miR-21 and miR-10b in modulating HCC progression and found that acidic microenvironment could clearly induce the expression of exosomal miR-21 and miR-10b in HCC in a HIF-1α and HIF-2α-dependent manner. Knockdown of miR-21 and miR-10b resulting in reduced levels in exosomes substantially decreased HCC cell proliferation, migration, and/or invasion, whereas restoration of miR-21 and miR-10b by knocking-down HIF-1α and HIF-2α- largely rescued the proliferation, migration, and invasion of HCC cells both *in vivo* and*in vitro*. Furthermore, we found that acidic pH- derived exosomes containing miR-21 and miR-10b strongly induced a pool of genes in recipient cells. Taken together, these results suggested that exosomal miR-21 and miR-10b induced by tumor acidic microenvironment play critical roles in promoting HCC cell growth and metastasis.

Given the importance of exosomal miR-21 and miR-10b in HCC development and/or aggressiveness, we investigated whether exosomal miR-21 and miR- 10b from the serum samples of E-HCC patients are biologically active. Our results demonstrated that the exosomes derived from E-HCC patients\' sera had elevated levels of miR-21 and/or miR-10b, which could substantially promote HCC cell proliferation and migration. We then further investigated whether serum exosomal miR-21 and miR-10b could serve as prognostic biomarkers and useful therapeutic targets for metastasis prevention in E-HCC patients. We found that the levels of serum exosomal miR-21 and miR-10b in E-HCC patients were positively associated with E-HCC advanced clinical stage as well as HIF-1α and HIF-2α expression in the tumor. More importantly, we demonstrated that a nano-drug designed to target miR-21 and miR-10b had therapeutic effects in inhibiting HCC in a xenograft mouse model. Thus, these results provide evidence that serum exosomal miR-21 and/or miR-10b may serve as prognostic biomarkers and potential therapeutic targets for E-HCC.

In summary, our results clearly showed that upregulation of exosomal miR-21 and/or miR-10b by the acidic microenvironment is a frequent oncogenic event in HCC critical for the acquisition of an aggressive/poor prognostic phenotype of the disease. Functional and mechanistic results demonstrated that exosomal miR-21 and miR-10b can drive the recipient cells towards a pro-metastatic phenotype. More importantly, our findings indicated that exosomal miR-21 and miR-10b may be novel therapeutic targets for E-HCC and potentially broaden the treatment options for this highly prevalent disease.
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:   early-stage hepatocellular carcinoma

pHi

:   intracellular pH

pHe

:   extracellular pH

GLUT-1

:   glucose transporter 1
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:   cholesteryl-4-((2-(4-morpholinyl)ethyl)amino)-4-oxoburanoate
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:   transarterial chemoembolization

LASSO

:   least absolute shrinkage and selection operator

DFS

:   Disease-free survival

OS

:   Overall survival. SYSUCC, Sun Yat-Sen University Cancer Center

PDCM

:   the nano-liposomes consisted by 1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine

PDCM-GLUT-1

:   GLUT-1 siRNA encapsulated in PDCM nano-particles

PDCM-CA9

:   CA9 siRNA is encapsulated in PDCM nano-particles.

![**Acidic microenvironment correlated with poor survival. A.** Expression of *GLUT-1* and *CA9* in HCC tissues and adjacent normal tissues in TCGA datasets. **B.** Correlation of overall survival and *GLUT-1/CA9* gene expression by Kaplan-Meier analysis in HCC patients in TCGA datasets. **C.** Correlation of *GLUT-1/CA9* expression and extracellular pH in 20 E-HCC patients\' fresh tissues *in vitro.* **D.** Expressions of *MMP3* and*MMP9* in SMMC-7721 cells cultured under pH 6.6 and pH 7.4 conditions. **E.** Correlation of *MMP3/MMP9* expression and extracellular pH in the 20 E-HCC patients\' fresh tissues*.***F.** Correlation of overall survival and *MMP3/MMP9* expression by Kaplan-Meier analysis in HCC patients in TCGA datasets. **G.** Correlation of disease-free survival and *MMP3/MMP9* gene expression by Kaplan-Meier analysis in E-HCC patients in SYSUCC datasets. **H.** Tumor volumes in PBS, NaHCO~3~, PDCM-ctrl, PDCM-CA9, PDCM-GLUT-1, and PDCM-CA9 + PDCM-GLUT-1 groups. **I.** Numbers of lung metastases numbers of cell groups as in (H). **J.** Extracellular pH of cell groups as in (H). \*, *P*\<0.05. \*\*, *P*\<0.01.](thnov09p1965g001){#F1}

![**Acidic HCC cell-derived exosomes promote migration and invasion of the non-acidic recipient HCC cells. A.** Western blots of CD63 and CD81 in exosomes derived from SMMC-7721 and Hep3B cells cultured under different pHs. **B.** Western blot analysis of HIF-1α and HIF-2α in normoxia. **C.** Transmission electron microscopy of exosomes isolated from the cell culture supernatant. **D.** Confocal microscopy of the Dil-labeled exosomes (red). **E.** MTT assays of the proliferation of recipient cells treated with acidic HCC-derived exosomes. **F.** Invasion of recipient cells treated with acidic HCC-derived exosomes. **G.** Migration of recipient cells treated with acidic HCC-derived exosomes. Experiments performed in triplicates. Non-Ac exo, the exosomes derived from HCC cells cultured in the non-acidic medium. Ac mock exo, exosomes derived from HCC cells cultured in the acidic medium. Ac ctrl shRNA exo, exosomes derived from HCC cells transfected by empty vector cultured in the acidic medium. Ac HIF-1 KD exo, exosomes derived from HIF-1α KD HCC cells cultured in the acidic medium. Ac HIF-2 KD exo, exosomes derived from HIF-2α KD HCC cells cultured in the acidic medium. Ac HIF-1+2 KD exo, exosomes derived from HIF-1α and HIF-2α KD HCC cells cultured in the acidic medium. \*, *P* \< 0.05. \*\*, *P* \< 0.01.](thnov09p1965g002){#F2}

![**Identification of functional miRNAs based on miRNA expression profiles of exosomes derived from acidic HCC cells and TCGA dataset. A.** The pie chart shows different miRNAs from acidic and non-acidic exosomes. **B.** Gene ontology (GO) analysis and KEGG analysis of miRNAs identified in (A). **C.** The volcano plot shows 84 differentially expressed miRNAs from 49 pairs of samples of TCGA dataset. **D.** 18 miRNAs identified by the LASSO logistic regression model with non-zero coefficients. **E.** Schematic illustration for the selection of candidate miRNAs.](thnov09p1965g003){#F3}

![**Acidic microenvironment induces exosomal miR-21 and miR-10b expression through HIF-1α or HIF-2α. A.** Comparison of the levels of miR-10b, miR-21, miR-223 and miR-940 from acidic and non-acidic media by RT-PCR. **B and C.** Comparison of the levels of cellular and exosomal miR-21 and miR-10b in HIF-1α or HIF-2α knockdown cells by RT-PCR. **D.** Binding of HIF-1α and HIF-2α to the predicted HRE regions in miR-21 and miR-10b promoters by ChIP assays. Input DNA was used as positive control and miR-130b was used as a negative control. **E.** Expression of cellular miR-21 and miR-10b in SMMC-7721 and Hep3B cells cultured under pH 6.6 and pH 7.4. **F.** The relationship between exosomal miR-21/miR-10b levels and pH in normal HCC cells and miR-21/miR-10b mimics-transfected HCC cells. Experiments performed in triplicates. \*, *P*\<0.05. \*\*, *P*\<0.01. Non-Ac condition, SMMC-7721 cells were cultured in pH 7.4 medium. Ac condition, SMMC-7721 cells were cultured in pH 6.6 medium. HIF-1 KD, HIF-1α KD SMMC-7721 cells. HIF-2 KD, HIF-2α KD SMMC-7721 cells. HIF-1+2 KD, HIF-1α and HIF-2α KD SMMC-7721 cells.](thnov09p1965g004){#F4}

![**miR-21 and miR-10b mediated acidic exosome-induced cell proliferation, migration, and invasion. A, F,** MTT assay; **B, D, G and I,** invasion assay; **C, E, H and J,** scratch assay of cancer cells modified as depicted in the Figure. Experiments performed in triplicates. \*, *P* \< 0.05.](thnov09p1965g005){#F5}

![**Acidic exosomal miR-21 and miR-10b promote tumor growth and metastasis in xenograft models. A.** miR-21 and miR-10b could bind to 3\' UTR of PTEN. Western blot analysis of PTEN, p-AKT, E-cadherin, mTOR, Snail and Vimentin. **B.** Tumor volumes in PBS, non-acidic exosome, miR-21 KD exosome, miR-10b KD exosome, miR-21 mimics exosome, miR-10b mimics exosome, and acidic exosome groups of cancer cells. **C.** Lung metastases numbers of groups of cancer cells as in (B). **D.** Western blot analysis of PTEN, E-cadherin, and Vimentin of cancer cells. **E.** Immunofluorescence staining of E-cadherin and Vimentin.](thnov09p1965g006){#F6}

![**Acidic serum exosomal miR-21 and miR-10b correlate with disease-free survival in E-HCC patients. A.** Electron micrograph of exosomes isolated from E-HCC patients\' sera.**B.** Levels of serum exosomal miR-21 and miR-10b between E-HCC patients and healthy volunteers.**C.** Proliferation of recipient cells treated with exosomes derived from E-HCC patients\' sera by the MTT assay.**D.** Migration and invasion of recipient cells treated with exosomes derived from E-HCC patients\' sera using the invasion assay and scratch assay.**E.** Kaplan-Meier analysis of the association between exosomal miR-21/miR-10b and E-HCC patients\' disease-free survival. **F.** ROC analysis of the sensitivity and specificity of exosomal miR-21 and miR-10b compared with tissue miR-21/miR-10b and AFP in 124 E-HCC patients. **G.** Tumor volumes of PBS, PDCM-ctrl, PDCM-miR-21, PDCM-miR-10b, PDCM-miR-21+PDCM-miR-10b groups of cancer cells. **H.** Numbers of lung metastases of groups of cells as in G. Experiments were performed in triplicates. \*, *P* \< 0.05. \*\*, *P* \< 0.01.](thnov09p1965g007){#F7}

###### 

Correlation of clinical-pathologic characteristics of serum exosomal miR-21 and miR-10b in 124 E-HCC patients.

  Variable                 All cases   Exosomal miR-21   P \*   Exosomal miR-10b   P \*        
  ------------------------ ----------- ----------------- ------ ------------------ ------ ---- -------
  **Age(years)**                                                                               
  ≥48                      61          28                33     0.479              34     27   0.289
  \<48                     63          33                30     29                 34          
  **Sex**                                                                                      
  Male                     115         59                56     0.164              59     56   0.741
  Female                   9           2                 7      4                  5           
  **Hepatitis history**                                                                        
  Yes                      108         51                57     0.293              50     58   0.014
  No                       16          10                6      13                 3           
  **AFP(ng/ml)**                                                                               
  ≤20                      35          21                14     0.164              20     15   0.428
  \>20                     89          40                49     43                 46          
  **Liver cirrhosis**                                                                          
  yes                      96          48                48     0.831              49     47   0.923
  no                       28          13                15     14                 14          
  **Tumor size(cm)**                                                                           
  ≤3                       44          37                17     0.005              31     13   0.001
  \>3                      80          34                46     32                 48          
  **Tumor multiplicity**                                                                       
  Signal                   98          49                49     0.826              52     46   0.255
  Multiple                 26          12                14     9                  15          
  **Differentiation**                                                                          
  Well-moderate            67          40                27     0.012              40     27   0.047
  Poor-undifferentiated    57          21                36     23                 34          
  **Recurrence**                                                                               
  No                       62          43                19     0.000              45     17   0.000
  Yes                      62          18                44     18                 44          
  **HIF-1α**                                                                                   
  Negative                 65          44                21     0.001              49     16   0.000
  Positive                 69          27                42     24                 45          
  **HIF-2α**                                                                                   
  Negative                 72          46                26     0.000              59     23   0.000
  Positive                 52          15                37     14                 38          

AFP: alpha fetoprotein; HIF: hypoxia-inducible factor.

###### 

Univariate and multivariable analyses of clinical characteristics with disease-free survival of patients with E-HCC.

  Clinical variable                                             Disease-free survival   
  ------------------------------------------------------------- ----------------------- -------
  **Univariate analysis**                                                               
  Age (≥48.4 years *vs.* \<48.4 years)                          0.902(0.547-1.486)      0.685
  Sex (Male *vs.* Female)                                       0.797(0.289-2.196)      0.661
  Hepatitis history (No *vs.* Yes)                              1.381(0.595-3.206)      0.453
  AFP (≤20 *vs.* \>20)                                          1.881(1.019-3.472)      0.043
  Liver cirrhosis (No *vs.* Yes)                                1.056(0.572-1.946)      0.863
  Tumor size (≤3cm *vs.* \>3cm)                                 2.621(1.462-4.699)      0.001
  Tumor multiplicity (Signal *vs.* Multiple)                    2.032(1.171-3.524)      0.012
  Differentiation (Well-moderate *vs.* Poor-undifferentiated)   1.165(0.707-1.920)      0.548
  Exosome miR-21(Low expression *vs.* High expression)          4.327(2.475-7.564)      0.000
  Exosome miR-10b (Low expression *vs.* High expression)        4.535(2.589-7.944)      0.000
  **Multivariable analysis**                                                            
  AFP (≤20 *vs.* \>20)                                          1.475(0.771-2.823)      0.240
  Tumor size (≤3cm *vs.* \>3cm)                                 1.841(0.988-3.430)      0.055
  Tumor multiplicity (Signal *vs.* Multiple)                    1.620(0.898-2.921)      0.109
  Exosome miR-21(Low expression *vs.* High expression)          2.446(1.252-4.777)      0.009
  Exosome miR-10b (Low expression *vs.* High expression)        2.550(1.301-4.997)      0.006
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